Having worked on more than 100 inter partes reviews and reexaminations, Margaux Savee has a thorough understanding of what it takes for clients to successfully navigate the patent post-grant review process. Adept at managing large and complex international patent portfolios, Margaux’s extensive patent prosecution, litigation and post-grant review experience allows her to achieve positive results for clients by successfully managing multi jurisdictional disputes, drafting patent licensing agreements and skillfully leading mediation and settlement negotiations.
She has managed post-grant review proceedings involving a variety of technologies, including medical devices, computer software and hardware, network architectures, and biotechnology. In addition, Margaux has litigated matters before the International Trade Commission and various U.S. District Courts. She also has appellate experience before the U.S. Court of Appeals for the Federal Circuit and U.S. Patent Trial and Appeal Board.
- Defended infringement suit before the District Court and ITC as well as managed several inter partes review proceedings before the Patent Trial and Appeal Board (PTAB) on behalf of a global manufacturer of CPAP devices, humidifiers, and masks. Successfully achieved settlement of global patent disputes.
- Managed and worked on several inter partes reexamination proceedings and argued before the Board of Patent Appeals and Interferences (BPAI, now PTAB) on behalf of a leading manufacturer of spinal implant devices.
- Worked on several inter partes reexaminations and appeals before the BPAI and U.S. Court of Appeals for the Federal Circuit on behalf of a multinational corporation that develops memory and semiconductor technologies.
- Managed and prepared several inter partes reexaminations relating to handheld portable devices and software, including their interconnectivity with personal computers, audio systems, and health monitoring systems on behalf of a Fortune 100 company best known for designing and developing consumer electronics.